Beyond Symptomatic Relief: Analyzing the Paradigm Shift in the Rare Neurodegenerative Disease Treatment Market Driven by Disease-Modifying Therapies.
The narrative surrounding rare neurodegenerative diseases has irrevocably changed. For decades, the focus was predominantly on mitigating debilitating symptoms associated with conditions like Spinocerebellar Ataxia (SCA) and Multiple System Atrophy (MSA). Today, the objective has pivoted entirely towards achieving disease modification, aiming to slow, halt, or even reverse the underlying...
0 Kommentare 0 Geteilt 503 Ansichten 0 Bewertungen